Tag Archives: Czech Academy of Sciences (CAS)

Rare-earth recycling (new method) can strengthen raw material independence

I wasn’t planning on celebrating my 7500th [March 9, 2026 correction: 7499th] post by publishing something from last July. Ah well. Here it is: a July 1, 2025 Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) press release (also on EurekAlert) announced research into recycling that could provide more critical minerals, in this case, rare earths, Note: Link have been removed,

The scientific team of Dr. Miloslav Polášek at IOCB Prague has developed a new method of separating the rare earth elements, or lanthanides, which are widely used in the electronic, medical, automotive, and defense industries. The unique method allows metals such as neodymium or dysprosium to be purified from used neodymium magnets. The environmentally friendly process precipitates the rare earths from water without organic solvents or toxic substances. The results were published in the Journal of the American Chemical Society (JACS) at the end of June [2025].

Global demand for rare earths is driven primarily by their use in extremely strong neodymium magnets, which enable efficient conversion of motion into electrical energy and vice versa. They are essential to manufacturers of electric cars, wind power plants, mobile phones, computers, and data centers. As these industries develop, demand for rare earths will continue to grow. However, the process of mining and purifying these elements is highly energy intensive and produces large amounts of toxic and radioactive waste.

The rare-earth market is dominated by China, giving it leverage over Europe and North America. It is therefore strategically advantageous to focus on so-called urban mining, i.e. the recycling, renewal, and reuse of materials from discarded equipment, such as electric vehicles, as a significant domestic source of rare earths.

“In the future, we won’t be able to cover the growing consumption of rare earths with primary mining. We know that within ten years at the latest, it will be necessary to manage these materials more carefully. In order to achieve this, the development of new technologies must start now,” explains Miloslav Polášek, head of the Coordination Chemistry group. “Our method solves the fundamental problems of recycling neodymium magnets. We can separate the right elements so that new magnets can be produced. Our process is environmentally friendly, and we believe that it will work on an industrial scale. Fortunately, unlike plastics, chemical elements don’t lose their properties through repeated processing, so their recycling is sustainable and can compensate for traditional mining.”

The topic, which Polášek’s group has been working on for a long time, is part of Kelsea G. Jones’s doctoral thesis. “We’ve developed a new type of chelator, which is a molecule that binds metal ions. This chelator specifically precipitates neodymium from dissolved magnets, while dysprosium remains in solution, and the elements are easily separated from each other. The method is also adaptable for the other rare earths found in neodymium magnets,” says Jones. “The separation is done in water and generates no hazardous waste. We achieve the same or better results than current industrial methods that rely on organic solvents and toxic reagents.”

The new technology is patented and responds to a fundamental global problem at the right time. “We’re impatiently awaiting the results of a feasibility study, which will help us direct this research from the laboratory into practice. I believe that in cooperation with the investors and business partners we’re approaching, this new technology from IOCB Prague has the potential to influence a wide range of industrial sectors,” says Milan Prášil, director of the transfer company IOCB Tech.

This research has also yielded another important finding: namely, that the element holmium is used in neodymium magnets of newer electric cars. Scientists from Polášek’s team discovered this by analyzing samples from the electric motors of European and Chinese cars. However, professional publications have not yet mentioned this fact, and most recycling projects do not take it into account when processing waste from electric cars. These findings will undoubtedly influence other development and recycling projects, even beyond the automotive industry.

….

Here’s a link to and a citation for the paper,

Macrocyclic Chelators for Aqueous Lanthanide Separations via Precipitation: Toward Sustainable Recycling of Rare-Earths from NdFeB Magnets by Kelsea G. Jones, Tomáš David, Martin Loula, Stanislava Matějková, Jan Blahut, Anatolij Filimoněnko, Miroslava Litecká, Jan Rohlíček, Jiří Böserle, Miloslav Polasek. Journal of the American Chemical Society (J. Am. Chem. Soc.) 2025, 147, 26, 22666–22676 DOI: https://doi.org/10.1021/jacs.5c04150 Published June 19, 2025 Copyright © 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0 .

This paper is open access.

Canadian Science Policy Centre presents a Science Diplomacy Symposium (European Union – Canada Scientific Collaboration in Horizon) on October 3, 2025 + a Sept. 10, 2025 event

Before getting to the October ‘collaboration’ event, here’s a brief overview of the European Union’s (EU) science funding programme. Once called a ‘framework’, they were designed to function in seven year increments with the last one bearing that name, the Seventh Framework, ending in 2013. It was succeeded by Horizon 2020 and, then, succeeded by Horizon Europe, which is due to wind down in 2027. You can read more about the programmes in the Horizon Europe Wikipedia entry where you’ll discover that the funding programme extended partnership status to Canada in January 2024. which is now one of the EU’s 27 partner countries

Horizon Europe and the University of Waterloo

I got a notice about this free September 10, 2025 event in Waterloo, Ontario courtesy of my August 23, 2025 Google alert. From the University of Waterloo’s Waterloo Institute for Nanotechnology (WIN) ‘Workshop on Strengthening Research Collaboration through Horizon Europe‘ event page,

The Office of Research and the Waterloo Institute for Nanotechnology (WIN) are pleased to co-host a distinguished delegation from the Czech Republic, presenting a workshop event on Strengthening Research Collaboration through Horizon Europe. The delegation includes representatives from three of the top-ranked universities in the Czech Republic: Charles University, Brno University of Technology, and the University of Chemistry and Technology, Prague.

This event will take place on Wednesday, September 10, 2025, from 10:00 AM to 12:00 PM, in QNC 1501. After the workshop, a networking lunch will be hosted from 12:00 PM to 1:00 PM.

All WIN members and the broader research community are invited to attend the workshop.

About the event: 

Objectives: 

Strengthening Research Collaboration through Horizon Europe: To explore and establish research cooperation under the Horizon Europe programme.

Focus:

  • The event focused primarily on Horizon Europe cooperation. Participants will contribute concrete topics for Horizon and R&D collaboration, which will be disseminated to encourage future partnerships. 
  • The participants’ expertise spans two main domains:
    • Engineering: advanced materials, manufacturing, and automation
    • Life Sciences: digital health solutions, transformational health technologies, health economics, and biotechnologies

Czech Republic Delegation

(To be updated)

NameAffliation 
Eva Libs BartonovaHead of Trade and Investment Section in Toronto
Jana BartosovaDirector of Center of Biomedical Technologies Transfer, University Hospital Hradec Králové           
Josef CernohorskyInstitute of Mechatronics and Computer Engineering, Technical University of Liberec
Richard CimlerHead of Centre for Advanced Technologies, University of Hradec Kralove
Jaroslav DemelFaculty of Economics, Technical University of Liberec
Rudolf FrycekCEO, Amires
Jana KolomaznikovaResearch Process Manager, Central Bohemian Innovation Centre
Vladimir KrylovDean, Faculty of Natural Science, Charles University
Kamil KucaBiotech Specialist, Betthera
HE [His Excellency] Radek MachůConsul General of the Czech Republic in Toronto
Ondřej MosCEO, The University Company TUL s.r.o.
Roman ParakSenior Research Scientist & Research Project Leader, Intemac
Lukas PeterVice-Dean for Cooperation with Industry, Faculty of Material Science, VŠB – Technical University of Ostrava
Martina PlisováHead of Tech Transfer, Institute of Biotechnology of the Czech Academy of Sciences           
Iveta SimberovaVice-Rector, Brno University of Technology
Prague [sic] Viola TokárováDepartment of Chemical Engineering, University of Chemistry and Technology [Prague]
Jan ValteraVice-Dean, Faculty of Mechanical Engineering, Technical University of Liberec

Waterloo Organizing Committee

NameAffiliation 
Scott InwoodDirector of Commercialization, University of Waterloo
Ashley HannonAssociate Director, Corporate Research Partnerships, Office of Research, University of Waterloo
Susan KaaiSenior Manager, International Research, Funding Agencies and Non-Profit Sponsors, University of Waterloo
Maria SuarezMarket Development Manager – Food Processing and Advanced Manufacturing, Waterloo Economic Development Corporation (EDC)
Ishari Waduwara-JayabahuInternational Relations Officer, Waterloo International, University of Waterloo
Dennis WongBusiness Development Manager, Waterloo Institute for Nanotechnology, University of Waterloo

The agenda will be finalized and updated later.

Registration

Act Now and send an email to WIN, dennis.wong@uwaterloo.ca and Office of Research, skaai@uwaterloo.ca, identifying which institutions and calls you are interested to connect with. It is possible to also propose any other consortia that you are interested in. 

Thank you!

I don’t often come across information about the Czech Republic’s science efforts. It’s always good to learn more.

Canadian Science Policy Centre (CSPC) and a Science Diplomacy Symposium (European Union – Canada Scientific Collaboration in Horizon)

An August 21, 2025 Canadian Science Policy Centre (CSPC) newsletter (received via email) announced a science diplomacy symposium being held in October 2025,

Upcoming Symposium:
European Union – Canada Scientific Collaboration 

CSPC and the Delegation of the European Union to Canada present the Science Diplomacy Symposium: European Union–Canada Scientific Collaboration in Horizon on October 3, 2025 in downtown Toronto. This in-person event will spotlight transatlantic research and innovation, exploring shared priorities, youth engagement, and global scientific leadership. Stay tuned for program and speaker announcements! Registration to this event is free but required as space is limited. 

To read more about the symposium, click here.

Register (for free) Here

Here’s more from the CSPC (Science Diplomacy Symposium) European Union – Canada Scientific Collaboration in Horizon event page,

The Canadian Science Policy Centre (CSPC) is pleased to announce its partnership with the European Union, through its Delegation to Canada, for the upcoming Science Diplomacy Symposium: European Union- Canada  Scientific Collaboration in Horizon.

This flagship event will highlight the European Union- Canada scientific cooperation, with a particular focus on Horizon Europe, the European Union’s largest research and innovation program. It will bring together European and Canadian leaders in research, innovation, and policy to explore the future of transatlantic scientific collaboration, spotlighting Horizon Europe as a powerful tool for advancing shared priorities between the European Union and Canada.

The event will feature three high-level panels:

  1. Advancing European Union-Canada Research and Innovation: Focus on Horizon Europe
  2. Building Global Scientific Leadership: Youth Engagement through Horizon Europe
  3. The Future of Scientific Collaboration between the European Union and Canada

Additional details on the program and speakers will be announced soon, so stay tuned!

For more information or questions related to this event, please email: info@sciencepolicy.ca

Science Diplomacy Symposium:

European Union – Canada Scientific Collaboration in Horizon

October 3, 2025 | Faculty Club, University of Toronto | 8:00 AM – 12:15 PM

Click Here to Register

*Registration to this event is free but required as space is limited.

As you see, there aren’t too many details. Hopefully there will be some announcement about the speakers soon.

It does appear to be an in person event only.

Background on the CSPC, science diplomacy, and Canada’s outreach

Much to my surprise, the CSPC has been organizing science diplomacy events for several years. How did I miss seeing them? (’nuff said) I have been able to fill in a few blanks with an undated document I stumbled across, ‘2nd National Symposium on “Science Diplomacy,” organized by CSPC’ found here: https://na.eventscloud.com/file_uploads/cb7066ca2c5ff2a3d9fd3786706c7b6a_2ndNationalSymposiumonScienceDiplomacyorganizedbyCSPC.pdf, from the final paragraph, Note: Three of the links failed to function and, so, were removed,

CSPC has been the leading Canadian institution in promoting dialogue and capacity building in science diplomacy among other science policy topics. CSPC held the first Science Diplomacy Session with Dr. Nina Federoff, former Science and technology adviser to US Secretary of State in 2010. In 2013, CSPC held the first of its kind national symposium on science diplomacy [link failed to function]. Similarly, in 2015, CSPC organized an invigorating symposium on diaspora scientists [link failed to function] highlighting Canada’s diverse scientific community and their natural disposition for promoting international collaboration and in strengthening Canada’s global position in scientific excellence. More recently, in June of this year, CSPC hosted a breakfast session at the Parliament Hill [ink failed to function] where Dr. Vaughan Turekian, Science Adviser to US Secretary of State, John Kerry, highlighted the importance of “Science Diplomacy in the 21st Century

Moving on to 2025, here’s some background on strengthening ties with Europe from a June 23, 2025 news release from the Prime Minister’s Office,

Today, the Prime Minister, Mark Carney, announced an historic step forward for Canada’s relationship with the European Union (EU). Together with President Costa and President von der Leyen, the Prime Minister announced they will forge a new, ambitious, and comprehensive partnership. The New EU-Canada Strategic Partnership of the Future is rooted in shared values and the rules-based international system, and strategically aimed to pursue common interests.

Canada and the EU will soon launch comprehensive negotiations across multiple areas to strengthen co-operation and connection – including trade and economic security, the digital transition, and the fight against climate change and environmental degradation. This will create more economic opportunities and long-term prosperity for workers, businesses, and citizens in both Canada and the EU.

As part of this new, strengthened relationship, Canada and the EU today signed the Security and Defence Partnership, which provides a framework for dialogue and co-operation in security and defence priorities. For Canada and the EU Member States who are NATO Allies, this will also help deliver on capability targets more quickly and economically. This new partnership is the intentional first step toward Canada’s participation in Security Action for Europe (SAFE), an instrument of the ReArm Europe Plan/Readiness 2030. Canada’s participation in this initiative will create significant defence procurement and industrial opportunities for Canada.

In an increasingly dangerous and divided world, Canada’s new government is focused on strengthening and diversifying our international partnerships. We will work with the EU and other allies to build a new international, rules-based system for a more secure and prosperous world.

Jessica Mundie’s June 25, 2025 article for the Canadian Broadcasting Corporation (CBC) news online specifies that Canada is not looking to be a member of the EU, Note: A link has been removed,

Prime Minister Mark Carney says Canada is “looking for a closer partnership” with the European Union — but not to become a member.

While speaking from the NATO summit in the Netherlands — where he announced Canada’s promise to spend five per cent of gross domestic product on defence by 2035 — Carney was asked whether he has given any thought to trying to join the bloc of European nations.

“The short answer is no,” he said. “That’s not the intent. That’s not the pathway we’re on.”

Certainly, there’s an interest in scientific collaboration as evidenced by this Horizon Europe webpage (modified on June 23, 2025) on the Innovation, Science and Economic Development Canada (ISED) website. Note: A link has been removed,

Horizon Europe is the world’s largest research and innovation funding program. It gives Canadians access to even more opportunities to elevate their research and innovations through global partnerships.

Funding is available to all types of organizations, including researchers, universities, small- and medium-sized enterprises, non-profit organizations, institutions and more.

With different pillars of funding for individual researchers or collaborative projects, Horizon Europe supports the world’s greatest scientific and innovative breakthroughs in research and development (R&D) and industrial competitiveness.

Pillar 2 includes six thematic clusters, each tackling specific themes to address societal issues and strengthening Europe’s industrial competitiveness.

While Canada was added as a partner to the Horizon Europe list in 2024, it seems active interest is increasing, On a related note, there are two upcoming episodes CSPC’s SciPol Digest podcast,

Episode 5

The Future of the Scientific International Cooperation in a Geopolitical Shift

In this episode, we will explore how global tensions and shifting alliances are reshaping international scientific collaboration, with insights from experts in science, policy, and diplomacy.

Coming Soon!

Episode 6

US and Canada scientific collaboration in 2025

This episode will examine the current landscape of research collaboration between Canada and the U.S., exploring how political shifts may impact joint initiatives, funding, and researcher mobility in 2025.

Coming Soon!

Whether we like it or not, we live in interesting times.

Gene editing to identify and change parts of chicken DNA and limit the spread of bird flu virus

This news comes from the University of Edinburgh (Scotland). From an October 10, 2023 news item on phys.org, Note: A link has been removed,

Scientists have used gene editing techniques to identify and change parts of chicken DNA that could limit the spread of the bird flu virus in the animals.

Researchers were able to restrict—but not completely block—the virus from infecting chickens by altering a small section of their DNA.

The birds showed no signs that the change in their DNA had any impact on their health or well-being.

The findings are an encouraging step forward, but experts highlight that further gene edits would be needed to produce a chicken population which cannot be infected by bird flu—one of the world’s most costly animal diseases.

An October 10, 2023 University of Edinburgh press release, which originated the news item, provides more detail about this research,

Gene editing

Scientists from University of Edinburgh, Imperial College London and the Pirbright Institute bred the chickens using gene editing techniques to alter the section of DNA responsible for producing the protein ANP32A. During an infection, flu viruses hijack this molecule to help replicate themselves.

When the ANP32A gene-edited chickens were exposed to a normal dose of the H9N2-UDL strain of avian influenza virus – commonly known as bird flu – 9 out of 10 birds remained uninfected and there was no spread to other chickens.

Partial protection

The research team then exposed the gene-edited birds to an artificially high dose of avian influenza virus to further test their resilience.

When exposed to the high dose, half of the group – 5 out of 10 birds – became infected. However, the gene edit did provide some protection, with the amount of virus in the infected gene-edited chickens much lower than the level typically seen during infection in non-gene-edited chickens.

The gene edit also helped to limit onward spread of the virus to just one of four non-gene-edited chickens placed in the same incubator. There was no transmission to gene-edited birds.

Viral evolution

Scientists found that in the ANP32A gene-edited birds, the virus had adapted to enlist the support of two related proteins – ANP32B and ANP32E – to replicate.

Following lab tests, scientists found that some of the mutations enabled the virus to utilise the human version of ANP32, but its replication remained low in cell cultures from the human airway.

Experts say that additional genetic changes would be needed for the virus to infect and spread effectively in humans.

However, the findings demonstrate that the single ANP32A gene edit is not robust enough for application in the production of chickens, according to the team.

Gene editing

Scientists from University of Edinburgh, Imperial College London and the Pirbright Institute bred the chickens using gene editing techniques to alter the section of DNA responsible for producing the protein ANP32A. During an infection, flu viruses hijack this molecule to help replicate themselves.

When the ANP32A gene-edited chickens were exposed to a normal dose of the H9N2-UDL strain of avian influenza virus – commonly known as bird flu – 9 out of 10 birds remained uninfected and there was no spread to other chickens.

Partial protection

The research team then exposed the gene-edited birds to an artificially high dose of avian influenza virus to further test their resilience.

When exposed to the high dose, half of the group – 5 out of 10 birds – became infected. However, the gene edit did provide some protection, with the amount of virus in the infected gene-edited chickens much lower than the level typically seen during infection in non-gene-edited chickens.

The gene edit also helped to limit onward spread of the virus to just one of four non-gene-edited chickens placed in the same incubator. There was no transmission to gene-edited birds.

Viral evolution

Scientists found that in the ANP32A gene-edited birds, the virus had adapted to enlist the support of two related proteins – ANP32B and ANP32E – to replicate.

Following lab tests, scientists found that some of the mutations enabled the virus to utilise the human version of ANP32, but its replication remained low in cell cultures from the human airway.

Experts say that additional genetic changes would be needed for the virus to infect and spread effectively in humans.

However, the findings demonstrate that the single ANP32A gene edit is not robust enough for application in the production of chickens, according to the team.

Further edits

To prevent the emergence of escape viruses – viruses that adapt to evade the gene edit and cause infection – the research team next targeted additional sections of DNA responsible for producing all three proteins – ANP32A, ANP32B and ANP32E – inside lab-grown chicken cells.

In cell cultures in the lab, growth of the virus was successfully blocked in cells with the three gene edits.

The next step will be to try to develop chickens with edits to all three genes. No birds have been produced yet.

The study highlights the importance of responsible gene editing and the need to be alert to the risks of driving viral evolution in unwanted directions if complete resistance is not achieved, experts say.

Bird flu is a major global threat, with a devastating impact in both farmed and wild bird populations. In the UK alone, the current outbreak of H5N1 bird flu has decimated seabird populations and cost the poultry industry more than £100 million in losses.

In rare instances, mutations in the bird flu virus allow it to infect people and cause serious illness. Efforts to control the spread of the disease are urgently needed.

“Bird flu is a great threat to bird populations. Vaccination against the virus poses a number of challenges, with significant practical and cost issues associated with vaccine deployment. Gene-editing offers a promising route towards permanent disease resistance, which could be passed down through generations, protecting poultry and reducing the risks to humans and wild birds. Our work shows that stopping the spread of avian influenza in chickens will need several simultaneous genetic changes.” Professor Mike McGrew, The study’s principal investigator, from the University of Edinburgh’s Roslin Institute

“This work is an exciting collaboration that fuses our expertise in virology with the world-leading genetic capability at the Roslin Institute. Although we haven’t yet got the perfect combination of gene edits to take this approach into the field, the results have told us a lot about how influenza virus functions inside the infected cell and how to slow its replication.” Professor Wendy Barclay, Imperial College London

The research was funded by UKRI-BBSRC, which also provides strategic funding to The Roslin Institute, and was supported by Edinburgh Innovations, the University’s commercialisation service.

Ryan O’Hare’s October 10, 2023 Imperial College London (ICL) press release offers a slightly different perspective on the same work, Note: A link has been removed,

Scientists have successfully used gene editing techniques to limit the spread of bird flu in chickens.

In a UK first, researchers have been able to restrict, but not completely block, the avian influenza virus from infecting the birds by precisely altering a small section of their DNA.

The modified birds showed no signs that the change had any impact on the animals’ health or well-being.

But the researchers say that while the findings are encouraging, further gene edits would be needed to produce chickens which cannot be infected by bird flu.

The study, carried out by researchers from the University of Edinburgh, Imperial College London and the Pirbright Institute, is published in the journal Nature Communications.

Professor Wendy Barclay, Head of the Department of Infectious Disease at Imperial College London, said: “This work is an exciting collaboration that fuses our expertise in virology with the world world-leading genetic capability at the Roslin Institute.

“Although we haven’t yet got the perfect combination of gene edits to take this approach into the field, the results have told us a lot about how influenza virus functions inside the infected cell and how to slow its replication.”

Global Threat

Bird flu is a major global threat, with a devastating impact in both farmed and wild bird populations. In the UK alone, the current outbreak of H5N1 bird flu has decimated seabird populations and cost the poultry industry more than £100 million in losses.

In the latest study, researchers aimed to test whether precise edits to the chicken’s genome could potentially generate birds which are resistant to the virus.

The team bred chickens with small edits to a gene called ANP32A. During an infection, influenza viruses hijack the ANP32A protein to help replicate themselves.

But when the gene-edited birds were exposed to a normal dose of virus (the H9N2 strain of avian influenza), 9 out of 10 birds remained uninfected and there was no spread to other chickens.

When the birds were exposed to an artificially high dose of virus, only half of them became infected. The single gene edit also provided some protection against transmission, with a much lower amount of virus in infected gene-edited birds compared to non-edited birds.

In addition, the edit also helped to limit onward spread of the virus to just one of four non-edited chickens placed in the same incubator. There was no transmission to gene-edited birds.

Triple edits

Analysis revealed that in the edited birds, the virus adapted to enlist the support of two related proteins to replicate – ANP32B and ANP32E.

Following lab tests, the researchers found some of the mutations may enable the virus to utilise the human version of ANP32, but replication remained low in cell cultures from the human airway. The researchers stress that additional genetic changes would be needed for the virus to have the potential to infect and spread effectively in humans.

According to the team, the findings demonstrate that a single gene edit is not robust enough to produce resistant chickens. To prevent the emergence of viruses able to adapt to the single edit, the team next used a triple edit to target additional proteins (ANP32A, ANP32B and ANP32E) in lab-grown chicken cells.

In cell cultures in the lab, growth of the virus was successfully blocked in cells with edits to all three genes. In future, researchers hope to develop chickens with this triple edit, but no birds have been produced at this stage.

According to the researchers, the study highlights the importance of responsible gene editing and the need to be alert to the risks of driving viral evolution in unwanted directions if complete resistance is not achieved, experts say.

Professor Mike McGrew, from the University of Edinburgh’s Roslin Institute and principal investigator of the study, said: “Bird flu is a great threat to bird populations. Vaccination against the virus poses a number of challenges, with significant practical and cost issues associated with vaccine deployment.

“Gene-editing offers a promising route towards permanent disease resistance, which could be passed down through generations, protecting poultry and reducing the risks to humans and wild birds. Our work shows that stopping the spread of avian influenza in chickens will need several simultaneous genetic changes.”

A non-gene-edited chicken (left) pictured next to an ANP32A gene-edited chicken (right). Image credit: Norrie Russell Courtesy: University of Edinburgh

There’s also an October 10, 2023 article by Jon Cohen for Science.org, which gives some idea of how much work it took to get to this point, Note: Links have been removed,

For 3 decades, Helen Sang has tinkered with the genomes of chickens to try to make the birds resistant to the flu viruses that periodically devastate flocks and raise fears of a human pandemic. Now, as an especially virulent strain of avian influenza sweeps through poultry and wild birds around the world, the geneticist at the University of Edinburgh’s Roslin Institute has her first solid success. Using the CRISPR gene editor and recent findings about what makes poultry vulnerable to flu, Sang and colleagues from three other institutions have created chickens that can resist real-life doses of avian flu viruses. “Sticking to it gets you somewhere in the end,” she says.

The result, published today [October 5, 2023] in Nature Communications, is “a long-awaited achievement,” says Jiří Hejnar, a virologist at the Czech Academy of Sciences’s Institute of Molecular Genetics whose group showed in 2020 that CRISPR-edited chickens could resist a cancer-causing virus. But farmers won’t be raising flu-proof chickens anytime soon. The edited birds still became infected when exposed to larger amounts of the flu virus. And the strategy raises a safety concern: chickens edited this way could, in theory, drive the evolution of flu variants better at infecting people. “What this showed is a proof of concept,” says Wendy Barclay, a virologist at Imperial College London who worked on the new study. “But we’re not there yet.”

Here’s a link to and a citation for the paper,

Creating resistance to avian influenza infection through genome editing of the ANP32 gene family by Alewo Idoko-Akoh, Daniel H. Goldhill, Carol M. Sheppard, Dagmara Bialy, Jessica L. Quantrill, Ksenia Sukhova, Jonathan C. Brown, Samuel Richardson, Ciara Campbell, Lorna Taylor, Adrian Sherman, Salik Nazki, Jason S. Long, Michael A. Skinner, Holly Shelton, Helen M. Sang, Wendy S. Barclay & Mike J. McGrew. Nature Communications volume 14, Article number: 6136 (2023) DOI: https://doi.org/10.1038/s41467-023-41476-3 Published: 10 October 2023

This paper is open access.

Combine a nonwoven nanotextile and unique compounds to treat skin infections

A September 30, 2021 news item on Nanowerk a new material for treating skin infections (Note: A link has been removed),

Researchers at the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague) and the Technical University of Liberec in collaboration with researchers from the Institute of Microbiology of the CAS, the Department of Burns Medicine of the Third Faculty of Medicine at Charles University (Czech Republic), and P. J. Šafárik University in Košice (Slovakia) have developed a novel antibacterial material combining nonwoven nanotextile and unique compounds with antibacterial properties (Scientific Reports, “Novel lipophosphonoxin-loaded polycaprolactone electrospun nanofiber dressing reduces Staphylococcus aureus induced wound infection in mice”).

A September 30, 2021 Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) press release (also on EurekAlert), which originated the news item, describes the work in more detail,

Because the number of bacterial strains resistant to common antibiotics is steadily increasing, there is a growing need for new substances with antibacterial properties. A very promising class of substances are the so-called lipophosphonoxins (LPPO) developed by the team of Dominik Rejman of IOCB Prague in collaboration with Libor Krásný of the Institute of Microbiology of the CAS.

“Lipophosphonoxins hold considerable promise as a new generation of antibiotics. They don’t have to penetrate the bacteria but instead act on the surface, where they disrupt the bacterial cell membrane. That makes them very efficient at destroying bacteria,” says Rejman.

“A big advantage of LPPO is the limited ability of bacteria to develop resistance to them. In an experiment lasting several weeks, we failed to find a bacteria resistant to these substances, while resistance to well-known antibiotics developed relatively easily,” explains Krásný.

The potential of LPPO is especially evident in situations requiring immediate targeted intervention, such as skin infections. Here, however, the substances must be combined with a suitable material that ensures their topical efficacy without the need to enter the circulatory system. This reduces the burden to the body and facilitates use.

One such suitable material is a polymer nanofiber developed by the team of David Lukáš of the Faculty of Science, Humanities and Education at the Technical University of Liberec. The researchers combined it with LPPO to prepare a new type of dressing material for bacteria-infected skin wounds. The material’s main benefit is that the antibacterial LPPO are released from it gradually and in relation to the presence and extent of infection.

“The research and development of the material NANO-LPPO is a continuation of the work carried out in a clinical trial on the NANOTARDIS medical device, which we recently successfully completed in collaboration with Regional Hospital Liberec, University Hospital Královské Vinohrady, and Bulovka University Hospital. With its morphological and physical-chemical properties, the device promotes the healing of clean acute wounds,” says Lukáš. “This collaboration with colleagues from IOCB Prague is really advancing the possibilities for use of functionalized nanofiber materials in the areas of chronic and infected wounds.”

“Enzymes decompose the nanomaterial into harmless molecules. The LPPO are an integral component of the material and are primarily released from it during this decomposition. Moreover, the process is greatly accelerated by the presence of bacteria, which produce lytic enzymes. This means that the more bacteria there are in the wound, the faster the material decomposes, which in turn releases more of the active substances into the affected site to promote healing and regeneration of soft tissues,” says Rejman in describing the action of the material.  

“Our experiments on mice confirmed the ability of NANO-LPPO to prevent infection in the wound and thus accelerate healing and regeneration. There was practically no spread of infection where we used the material. If clinical trials go well, this could be a breakthrough in the treatment of burns and other serious injuries where infection poses an acute threat and complication to treatment,” explains wound care specialist Peter Gál of the Department of Burns Medicine at Charles University’s Third Faculty of Medicine, the Faculty of Medicine at P. J. Šafárik University in Košice, and the East Slovak Institute for Cardiovascular Diseases.  

In terms of applications, NANO-LPPO is an interesting material for manufacturers of medicinal products and medical devices. Its commercialization is being coordinated through a collaborative effort between IOCB TECH, a subsidiary of IOCB Prague, and Charles University Innovations Prague, a subsidiary of Charles University, both of which were created for the purpose of transferring results of academic research to practice. The companies are currently seeking a suitable commercial partner.

Here’s a link to and a citation for the paper,

Novel lipophosphonoxin-loaded polycaprolactone electrospun nanofiber dressing reduces Staphylococcus aureus induced wound infection in mice by Duy Dinh Do Pham, Věra Jenčová, Miriam Kaňuchová, Jan Bayram, Ivana Grossová, Hubert Šuca, Lukáš Urban, Kristýna Havlíčková, Vít Novotný, Petr Mikeš, Viktor Mojr, Nikifor Asatiani, Eva Kuželová Košťáková, Martina Maixnerová, Alena Vlková, Dragana Vítovská, Hana Šanderová, Alexandr Nemec, Libor Krásný, Robert Zajíček, David Lukáš, Dominik Rejman & Peter Gál. Scientific Reports volume 11, Article number: 17688 (2021) DOI: https://doi.org/10.1038/s41598-021-96980-7 Published: 03 September 2021

This paper is open access.